Colorectal cancer incidence is increasing among young adults
the ONA take:
Screening efforts have resulted in an overall decrease in incidence of colorectal cancer (CRC). However, incidence of the disease in young adults (ages 20-39 years) has increased in the past 20 to 30 years.
Little is known about CRC incidence in young adults because recommended screening for people of average risk person begins at age 50 years. Researchers at the University of California, Irvine, analyzed 231,544 CRC cases from 1988-2009 from the California Cancer Registry to identify high-risk subgroups.
Their study cases included 5,617 young adults ages 20-39 years. Although the absolute incidence of CRC per 100,000 in this group was low, the researchers found CRC incidence increasing over time among both males and females, particularly for distal colon cancer in Hispanic females ages 20-29 years.
The researchers conclude that absolute incidence of CRC is significantly lower in among the young adult populations; however, incidence is increasing among young adults compared with the older screened population. They also note a need for further research to better characterize young adults at increased risk for CRC.
Incidence of colorectal cancer in young adults has increased in the past 20 to 30 years.
Sign Up for Free e-newsletters
- Leukemia Risk in Children, Maternal Use of Hormonal Contraception Linked in Population Study
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Molecular Features May Predict Response in Primary Pancreatic Cancer
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Counseling Patients on Oral Chemotherapy
- Patients and Caregivers Worry About Cost of Cancer Care
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|